Pfizer (PFE)
|
26.84
-0.12 (-0.45%)
|
|
|
|
PFE SEC filings
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
Special Offers
PFE earnings
Date
Actual
Expected
Prev Yr Qtr
7/31/2012
0.62
0.54
0.60
5/1/2012
0.58
0.56
0.60
1/31/2012
0.50
0.47
0.47
Pfizer (PFE) Upgrades
Date
Analyst
Old Rating
New Rating
11/01/2010
Bernstein
Market Perform
Outperform
10/20/2010
Cowen & Co
Neutral
Outperform
02/12/2009
Leerink Swann
Market Perform
Outperform
01/12/2009
Goldman Sachs
Sell
Neutral
10/20/2008
Barclays Capital
Equal Weight
Overweight
02/29/2008
Lehman Bros.
Underweight
Equalweight
Pfizer (PFE) Downgrades
Date
Analyst
Old Rating
New Rating
06/05/2008
Goldman Sachs
Buy
Neutral
07/18/2007
HSBC Securities
Overweight
Neutral
04/23/2007
Prudential Equity
Neutral Weight
Overweight
01/23/2007
Bear Stearns
Peer Perform
Outperform
12/04/2006
Morgan Stanley
N/ A
12/04/2006
Merrill Lynch
Neutral
Buy
Pfizer (PFE) New Coverage
Date
Analyst
Rating
09/28/2012
BMo Capital
Outperform
04/10/2012
ISI Group
Buy
05/21/2010
Jefferies & Co
Buy
09/10/2009
Morgan Stanley
Overweight $ 19 Target
12/11/2008
Soleil Securities
Buy
11/14/2008
Banc of America
Buy
